CD274 and neoplasm: Further histopathologic, immunohistochemical, and molecular pathologic analysis revealed a pulmonary adenocarcinoma with a PD-L1 tumor proportion score of <1%, an EGFR and a BRAF wild type and TP53 mutation (p.H179R; p.E271).